Hisun operates a globally integrated network of 4 manufacturing facilities. Our best-in-class facilities are built to manufacture and deliver a wide range of active pharmaceutical products (API) and finished dose products, to more than 60 countries. All facilities follow strict quality, safety, and environmental standards as upheld and outlined by government bodies and leading regulators such as US FDA, EMA, TGA and others.

 For more information, please contact:

Peggy Albanese
Director Business Development and Sales
Hisun Pharmaceuticals USA, Inc.
200 Crossing Blvd, 2nd Floor
Bridge, NJ 08807 
Office: 609-454-0237
Email: Peggy.Albanese@hisunusa.com


Solid Dosage Capacity

Pilot Plant

Production Plant


API Manufacturing Capacity

Chemical Synthesis



Injectable Capacity


    The largest Capacity in China for lyphillization of sterile pharmaceuticals


  • Gravimetrically controlled fill checks
  • Low particle aseptic techniques
  • Protection of photosensetive products
  • Inert headspace atmosephere in the container
  • Automatic stoppering and traying



Mammalian and microbial 


Animal Health


  • Injection(Suspension) 
  • Injection
  • Intramammary infusion 
  • Oral solution / Shampoo 
  • Toothpaste / premix 
  • Tablets / premix